Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Por um escritor misterioso
Descrição
Cancer in the Midst of COVID-19, A Report
Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study - The Lancet Diabetes & Endocrinology
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study - The Lancet Oncology
Vaccines, Free Full-Text
Cancers, Free Full-Text
Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19: Molecular Therapy
Vaccines, Free Full-Text
Covid vaccine efficacy and blood cancer
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in Molecular Medicine
Cancer in the Midst of COVID-19, A Report
de
por adulto (o preço varia de acordo com o tamanho do grupo)
/i.s3.glbimg.com/v1/AUTH_08fbf48bc0524877943fe86e43087e7a/internal_photos/bs/2021/Q/a/8eSd4VTNWbPBGZDHcmLg/2015-11-23-screen-shot-2015-11-20-at-13759-pm1-1.png)
